Cargando…
Type 17 Immune Response Facilitates Progression of Inflammation and Correlates with Cognition in Stable Schizophrenia
Dysregulation of the type 17 immune pathway has already been considered in schizophrenia and we previously measured decreased sera values of interleukin (IL)-17 in early stages. We further explored the possible correlation of IL-17 systemic levels with proinflammatory cytokines and cognitive scores...
Autores principales: | Borovcanin, Milica M., Minic Janicijevic, Slavica, Jovanovic, Ivan P., Gajovic, Nevena M., Jurisevic, Milena M., Arsenijevic, Nebojsa N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698203/ https://www.ncbi.nlm.nih.gov/pubmed/33182582 http://dx.doi.org/10.3390/diagnostics10110926 |
Ejemplares similares
-
Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition
por: Minic Janicijevic, Slavica, et al.
Publicado: (2022) -
Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia
por: Borovcanin, Milica M., et al.
Publicado: (2022) -
Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
por: Borovcanin, Milica Milovan, et al.
Publicado: (2017) -
IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis
por: Borovcanin, Milica M., et al.
Publicado: (2018) -
Anemia of inflammation in patients with colorectal cancer: Correlation with interleukin-1, interleukin-33 and galectin-1
por: Jocić, Miodrag, et al.
Publicado: (2022)